Publications by authors named "Frederic Di Fiore"

Claim this Profile
R
Real-world treatment patterns and survival outcomes in patients with metastatic castration-resistant prostate cancer in France: lessons from the prospective OPALE study.
Josephine Papet, Laetitia Augusto-Pelegrin, François Christy, Justine Lequesne, Frederic Di Fiore

Anticancer Drugs· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (PRODIGE 62-FFCD 1701-OESIRI).
David Tougeron, Laurent Mineur, Aziz Zaanan, Melissa Kadi, Catherine Poisson Ligeza, Frédéric Di Fiore

Eur J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early ctDNA and Survival in Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors: A Secondary Analysis of the SAMCO-PRODIGE 54 Randomized Clinical Trial.
Julien Taïeb, Francesco Giulio Sullo, Aurélie Lecanu, Camille Bourreau, Emilie Barbier, Frederic Di Fiore

JAMA Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of circulating HER2 extracellular domain in patients with HER2-positive metastatic breast carcinoma treated with TDM-1 (trastuzumab emtansine).
Roman Vion, Céline Calbrix, Anca Berghian, Emilie Lévêque, Maxime Fontanilles, Frédéric Di Fiore

Clin Transl Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma.
Michel Ducreux, Romain Desgrippes, Yves Rinaldi, Frédéric Di Fiore, Rosine Guimbaud

J Clin Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ctDNA variations according to treatment intensity in first-line metastatic colorectal cancer.
Adrien Grancher, Ludivine Beaussire-Trouvay, Virginie Vernon, Marie Dutherage, Valérie Blondin, Frédéric Di Fiore

Br J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative dose intensity of gemcitabine-nab-paclitaxel combination as second-line or more in locally advanced or metastatic pancreatic adenocarcinoma.
Adrien Grancher, Leila Tagemouati, André Gillibert, Lilian Schwarz, Virginie Vernon, Frédéric Di Fiore

Clin Res Hepatol Gastroenterol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERBB2 Comprehensive Profiling and Prognostication in Stage III Colon Cancer: Findings From PETACC8 and IDEA-France Cohorts.
Camilla Pilati, Audrey Soulabaille, Claire Gallois, Hélène Blons, Anne Cayre, Frédéric Di Fiore

Gastroenterology· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain and Health-related Quality of Life with Biweekly Versus Triweekly Cabazitaxel Schedule in Older Men with Metastatic Castration-resistant Prostate Cancer in the Multicenter, Randomized CABASTY Trial.
Stephane Oudard, Yohann Tran, Carole Helissey, Charles Vauchier, Raffaele Ratta, Frederic Di Fiore

Eur Urol Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical impact of EGFR alterations in elderly glioblastoma patients: results from a real-life cohort.
Séréna Pulcini, Ludivine Beaussire-Trouvay, Florent Marguet, Pierre-Julien Viailly, Olivier Langlois, Fréderic Di Fiore

J Neurooncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative dose intensity of first-line triplet chemotherapy in metastatic colorectal cancer.
Julien Hoba, Adrien Grancher, Vincent Hautefeuille, Anthony Turpin, Karine Bouhier-Leporrier, Aude Di Fiore, Frédéric Di Fiore

Dig Liver Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resection of colorectal liver metastases with second-line aflibercept plus FOLFIRI: Results from the RESECTION prospective French cohort.
David Tougeron, Frederic Bibeau, Benoist Chibaudel, Stefano Kim, Thierry Nguyen, Frederic DiFiore

Eur J Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Biomarkers to Define a Biological Borderline Situation for Pancreatic Adenocarcinoma: Results of an Ancillary Study of the PANACHE01-PRODIGE48 Trial.
Jean Pinson, Julie Henriques, Ludivine Beaussire, Nasrin Sarafan-Vasseur, Antonio Sa Cunha, Frederic Di Fiore

Ann Surg· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Where do we stand with screening for colorectal cancer and advanced adenoma based on serum protein biomarkers? A systematic review.
Adrien Grancher, Steven Cuissy, Hélène Girot, André Gillibert, Frédéric Di Fiore

Mol Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SUNLAND: a randomized, double-blinded phase II GERCOR trial of sunitinib versus placebo and lanreotide in patients with advanced progressive midgut neuroendocrine tumors.
Pascal Hammel, Denis Smith, Pauline Afchain, Sophie Dominguez-Tinajero, Jean-François Seitz, Frédéric Di Fiore

Ther Adv Med Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic remodeling in glioblastoma: a longitudinal multi-omics study.
Maxime Fontanilles, Jean-David Heisbourg, Arthur Daban, Frederic Di Fiore, Louis-Ferdinand Pépin

Acta Neuropathol Commun· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trifluridine/tipiracil + oxaliplatin ± nivolumab vs FOLFOX ± nivolumab in HER2 negative advanced oesogastric adenocarcinoma: The PRODIGE73-UCGI40-LOGICAN trial.
Damien Botsen, Sylvie Chabaud, Hervé Perrier, Hanifa Ammarguellat, Véronique Jestin-Le-Tallec, Frédéric Di Fiore

Dig Liver Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases.
Thomas Aparicio, Julie Henriques, Magali Svrcek, Aziz Zaanan, Sylvain Manfredi, Frédéric Di Fiore

Br J Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of HPV circulating tumor DNA detection and quantification in locally advanced cervical cancer.
Ludivine Beaussire-Trouvay, Orianne Duhamel, Anne Perdrix, Emilie Lévêque, Roman Vion, Frédéric Di Fiore

Front Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical Trial.
David Tougeron, Laetitia Dahan, Ludovic Evesque, Karine Le Malicot, Farid El Hajbi, Frédéric Di Fiore

JAMA Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability.
Mathilde Moreau, Emily Alouani, Clémence Flecchia, Antoine Falcoz, Claire Gallois, Frederic Di Fiore

Eur J Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of circulating short-length DNA fragments in unresected glioblastoma patients.
Arthur Daban, Ludivine Beaussire-Trouvay, Émilie Lévêque, Cristina Alexandru, Isabelle Tennevet, Frédéric Di Fiore

Transl Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Contributions of molecular biology to the management of colorectal cancer].
Adrien Grancher, Steven Cuissy, David Sefrioui, Frédéric Di Fiore

Rev Prat· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biweekly vs Triweekly Cabazitaxel in Older Patients With Metastatic Castration-Resistant Prostate Cancer: The CABASTY Phase 3 Randomized Clinical Trial.
Stéphane Oudard, Raffaele Ratta, Eric Voog, Philippe Barthelemy, Antoine Thiery-Vuillemin, Frederic Di Fiore

JAMA Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma.
Aurélien Drouyer, Ludivine Beaussire, Pauline Jorda, Marianne Leheurteur, Cécile Guillemet, Frédéric Di Fiore

BMC Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis